🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📉 Price Drop 6.4%

        February 24, 2026

🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📉 Price Drop 6.4%

        🚨 Alpha Bond Signal Alert
Bond Market Analysis
Hanwha Life Insurance Co., Ltd. (088350.KS) -6.4% at 2026-02-24 13:41 JST from 2026-02-24 12:00 JST

🕒 Time (Local)
🌐 English Summary
📰 Original Headline (linked)

2026-02-24 08:31 KST
KB Securities points out that 4Q25 standalone net income was a 25bn KRW loss, missing consensus, with retained CSM down 4.3% YoY to 8.7trn KRW and the K‑ICS solvency ratio slipping to 157%; it maintains only a Hold rating and stresses that visible turnaround requires improvement in these weakened profitability and capital metrics. (newspim.com)
[\[리포트 브리핑\]한화생명, '실적 개선을 위해 확인할 것이 아직 많이 남아 있다' 목표가 6,000원 - KB증권](https://www.newspim.com/news/view/20260224000094)

2026-02-24 08:10 KST
Meritz Securities describes Hanwha Life’s 4Q25 results as an “earnings shock,” noting a 25bn KRW net loss versus a market expectation of 688bn KRW profit, a 3.8% YoY decline in CSM to 8.7trn KRW, negative distributable (dividendable) profit due to large surrender value reserves, and a K‑ICS ratio down to 157%, all highlighting pressure on capital and future shareholder returns despite some recovery in insurance profit. (etoday.co.kr)
메리츠證 “한화생명, 실적은 ‘쇼크’지만 손익 회복 중⋯목표가↑”

2026-02-23 19:16 KST
Based on a DART filing, DigitalToday reports that on a separate (parent‑only) basis Hanwha Life recorded a 4Q25 net loss of 24.96bn KRW, swinging to a loss from the prior year, with revenue slightly down and operating profit plunging over 80% YoY, signaling a sharp deterioration in standalone profitability. (m.news.nate.com)
한화생명, 2025년4분기 당기순손실 24억9600만원…전년 동기 대비 적자전환

2026-02-23 18:04 KST
TopDaily highlights a “dilemma” over resuming dividends: Hanwha Life has suspended cash dividends for 2024–2025, its K‑ICS solvency ratio has declined to about 157% with Tier‑1 capital around 58%, and surrender value reserves are projected to exceed retained earnings, implying that distributable profit and the near‑term likelihood of dividend payments remain very limited. (en.topdaily.kr)
Hanwha Life Insurance The 'dilemma' of resuming dividends with surrender refund reserves exceeding profits

2026-02-23 15:43 KST
Yonhap reports that 2025 full‑year net income was 836.3bn KRW, down 3.4% from a year earlier, confirming a year‑on‑year decline in bottom‑line earnings even as operating profit and sales grew, which can weigh on valuation after the recent sharp share‑price run‑up. (en.yna.co.kr)
Hanwha Life Insurance 2025 net profit down 3.4 pct to 836.3 bln won

2026-02-23 15:39 KST
An Infostock article summarizing Hanwha Life’s DART “잠정실적” disclosure notes that 4Q25 consolidated net income fell 51.5% YoY to 674.07bn KRW and controlling‑shareholder net income dropped 85.4% YoY, with operating profit and pre‑tax profit also down sharply versus both the prior quarter and prior year, underscoring a significant earnings deterioration. (stock.mk.co.kr)
한화생명, 25년4분기 연결 영업이익 1,802.98억원

                                Don't miss what's next. Subscribe to Morning Espresso:

            Email address (required)

                    ← Newer

                🚨 Alpha Signal: Daewoo Engineering & Construction Co., Ltd. (047040.KS) 📈 Price Surge 7.5%

                    Older →

                🚨 Alpha Signal: SK Innovation Co., Ltd. (096770.KS) 📈 Price Surge 6.5%

🕒 Time (Local)	🌐 English Summary	📰 Original Headline (linked)
2026-02-24 08:31 KST	KB Securities points out that 4Q25 standalone net income was a 25bn KRW loss, missing consensus, with retained CSM down 4.3% YoY to 8.7trn KRW and the K‑ICS solvency ratio slipping to 157%; it maintains only a Hold rating and stresses that visible turnaround requires improvement in these weakened profitability and capital metrics. (newspim.com)	[\[리포트 브리핑\]한화생명, '실적 개선을 위해 확인할 것이 아직 많이 남아 있다' 목표가 6,000원 - KB증권](https://www.newspim.com/news/view/20260224000094)
2026-02-24 08:10 KST	Meritz Securities describes Hanwha Life’s 4Q25 results as an “earnings shock,” noting a 25bn KRW net loss versus a market expectation of 688bn KRW profit, a 3.8% YoY decline in CSM to 8.7trn KRW, negative distributable (dividendable) profit due to large surrender value reserves, and a K‑ICS ratio down to 157%, all highlighting pressure on capital and future shareholder returns despite some recovery in insurance profit. (etoday.co.kr)	메리츠證 “한화생명, 실적은 ‘쇼크’지만 손익 회복 중⋯목표가↑”
2026-02-23 19:16 KST	Based on a DART filing, DigitalToday reports that on a separate (parent‑only) basis Hanwha Life recorded a 4Q25 net loss of 24.96bn KRW, swinging to a loss from the prior year, with revenue slightly down and operating profit plunging over 80% YoY, signaling a sharp deterioration in standalone profitability. (m.news.nate.com)	한화생명, 2025년4분기 당기순손실 24억9600만원…전년 동기 대비 적자전환
2026-02-23 18:04 KST	TopDaily highlights a “dilemma” over resuming dividends: Hanwha Life has suspended cash dividends for 2024–2025, its K‑ICS solvency ratio has declined to about 157% with Tier‑1 capital around 58%, and surrender value reserves are projected to exceed retained earnings, implying that distributable profit and the near‑term likelihood of dividend payments remain very limited. (en.topdaily.kr)	Hanwha Life Insurance The 'dilemma' of resuming dividends with surrender refund reserves exceeding profits
2026-02-23 15:43 KST	Yonhap reports that 2025 full‑year net income was 836.3bn KRW, down 3.4% from a year earlier, confirming a year‑on‑year decline in bottom‑line earnings even as operating profit and sales grew, which can weigh on valuation after the recent sharp share‑price run‑up. (en.yna.co.kr)	Hanwha Life Insurance 2025 net profit down 3.4 pct to 836.3 bln won
2026-02-23 15:39 KST	An Infostock article summarizing Hanwha Life’s DART “잠정실적” disclosure notes that 4Q25 consolidated net income fell 51.5% YoY to 674.07bn KRW and controlling‑shareholder net income dropped 85.4% YoY, with operating profit and pre‑tax profit also down sharply versus both the prior quarter and prior year, underscoring a significant earnings deterioration. (stock.mk.co.kr)	한화생명, 25년4분기 연결 영업이익 1,802.98억원